BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11590650)

  • 1. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis.
    Pathak AP; Schmainda KM; Ward BD; Linderman JR; Rebro KJ; Greene AS
    Magn Reson Med; 2001 Oct; 46(4):735-47. PubMed ID: 11590650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.
    Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM
    Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
    Ellingson BM; Zaw T; Cloughesy TF; Naeini KM; Lalezari S; Mong S; Lai A; Nghiemphu PL; Pope WB
    J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study.
    Yan N; Zheng Y; Yang C
    Drug Des Devel Ther; 2017; 11():2931-2936. PubMed ID: 29042753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms.
    Parikh AH; Smith JK; Ewend MG; Bullitt E
    Technol Cancer Res Treat; 2004 Dec; 3(6):585-90. PubMed ID: 15560716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR evaluation of vessel size imaging of human gliomas: Validation by histopathology.
    Kellner E; Breyer T; Gall P; Müller K; Trippel M; Staszewski O; Stein F; Saborowski O; Dyakova O; Urbach H; Kiselev VG; Mader I
    J Magn Reson Imaging; 2015 Oct; 42(4):1117-25. PubMed ID: 25683112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of microvascular cerebral blood flux and late-stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI.
    Reynaud O; Geffroy F; Ciobanu L
    NMR Biomed; 2013 Jun; 26(6):699-708. PubMed ID: 23335424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
    Leu K; Enzmann DR; Woodworth DC; Harris RJ; Tran AN; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    Cancer Imaging; 2014 Nov; 14(1):31. PubMed ID: 25608485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.
    Jain R; Gutierrez J; Narang J; Scarpace L; Schultz LR; Lemke N; Patel SC; Mikkelsen T; Rock JP
    AJNR Am J Neuroradiol; 2011 Feb; 32(2):388-94. PubMed ID: 21071537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours.
    Haroon HA; Patankar TF; Zhu XP; Li KL; Thacker NA; Scott MJ; Jackson A
    Br J Radiol; 2007 Mar; 80(951):161-8. PubMed ID: 17303617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.
    Siegal T; Rubinstein R; Tzuk-Shina T; Gomori JM
    J Neurosurg; 1997 Jan; 86(1):22-7. PubMed ID: 8988077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cerebral blood volume (CBV) measured by dynamic susceptibility contrast MRI and 99mTc-RBC SPECT.
    Engvall C; Ryding E; Wirestam R; Holtås S; Ljunggren K; Ohlsson T; Reinstrup P
    J Neurosurg Anesthesiol; 2008 Jan; 20(1):41-4. PubMed ID: 18157024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI.
    Quarles CC; Schmainda KM
    Magn Reson Med; 2007 Apr; 57(4):680-7. PubMed ID: 17390352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D.
    Moffat BA; Chen M; Kariaapper MS; Hamstra DA; Hall DE; Stojanovska J; Johnson TD; Blaivas M; Kumar M; Chenevert TL; Rehemtulla A; Ross BD
    Clin Cancer Res; 2006 Mar; 12(5):1525-32. PubMed ID: 16533777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology.
    Cha S; Johnson G; Wadghiri YZ; Jin O; Babb J; Zagzag D; Turnbull DH
    Magn Reson Med; 2003 May; 49(5):848-55. PubMed ID: 12704767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.